Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: OPen Label Study to Evaluate Long Term Treatment Effect of DiaPep277 [Phase 3]
A Phase 3 open-label trial evaluating long-term effects of DiaPep277 in Type 1 diabetes was terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR. [Phase 2]
Phase II randomized, open-label study evaluating pegaptanib (Macugen) intravitreal injections plus panretinal photocoagulation for high-risk…
-
CLINICAL_TRIALS withdrawal · 2015-03-19Clinical Trial Update: Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 Diabetes [Phase 1]
The inpatient trial evaluating the MD-Logic Artificial Pancreas System for Type 1 diabetes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus [Phase 2]
An open-label Phase 2 trial assessing the safety and efficacy of DIABECELL in patients with Type 1 diabetes mellitus. The trial has complete…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Roles of T Helper 1 Cytokines in Type 1 Diabetes
The completed trial examined how T helper 1 cytokines influence type 1 diabetes. It highlights immune mechanisms that may drive beta-cell de…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Impact of ELKa, the Toolset for Food Exchanges Calculation on Metabolic Control in Pediatric Diabetic Patients. [NA]
Clinical trial evaluating ELKa, a toolset for calculating food exchanges, for its effect on metabolic control in pediatric Type 1 diabetes; …
-
CLINICAL_TRIALS trial_result · 2015-03-13Clinical Trial Update: Liraglutide in the Treatment of Type 1 Diabetes Mellitus [Phase 3]
A Phase 3 trial evaluating liraglutide for treatment of Type 1 Diabetes Mellitus has completed with results posted in 2015.
-
FDA approval · 2015-03-12FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
FDA approves a supplemental application for AFREZZA (insulin human) from MannKind Corporation. The approval relates to labeling/indication e…
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: Accu-Chek Combo in Young Patients
This clinical trial update reports the completion of a study evaluating Accu-Chek Combo in young patients with Type 1 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes [Phase 2]
Phase 2 trial evaluating AC2993 with or without immunosuppression on beta cell function in Type 1 diabetes; the study has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Prevention of Hypoglycaemia With Predictive Insulin Suspend Using Sensor Augmented Insulin Pump in Children [NA]
This completed study evaluated whether predictive insulin suspend with a sensor-augmented insulin pump can prevent hypoglycemia in children …
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: PETS-D (Parent Education Thru Simulation-Diabetes) [Phase 3]
Phase 3 trial PETS-D (Parent Education Through Simulation) for Type 1 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Changing Diabetes in Children
A Novo Nordisk-sponsored pediatric diabetes trial (NCT02382757) has been terminated, ending the study on changing diabetes in children.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus [Phase 2]
A Phase 2 clinical trial evaluating Symlin (pramlintide) in adolescents with Type 1 Diabetes Mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Bone Marrow as an Alternative Site for Islet Transplantation [NA]
The trial exploring bone marrow as an alternative site for islet transplantation has completed. No detailed results are provided in the snip…
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes [Phase 1]
A Phase 1 clinical trial update evaluating the pharmacodynamic and pharmacokinetic properties of insulin degludec/insulin aspart in adults w…
-
FDA label_change · 2015-03-03FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental labeling application for APIDRA (insulin glulisine) from Sanofi-aventis U.S. LLC, updating the product labeling.
-
FDA approval · 2015-03-03FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS research · 2015-03-03Clinical Trial Update: Hypothalamo-pituitary Adrenal Axis Activity and Neuropsychological Consequences in Type 1 Diabetes in Childhood
A clinical trial update describing a study on hypothalamo-pituitary-adrenal axis activity and its neuropsychological consequences in childre…
-
CLINICAL_TRIALS trial_result · 2015-02-26Clinical Trial Update: Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls
This completed clinical trial compared skin blood flow between people with Type 1 diabetes mellitus and healthy controls to assess microvasc…
-
FDA approval · 2015-02-25FDA Approved: TOUJEO — Original Application (Sanofi-Aventis U.S. LLC)
FDA approved Toujeo (insulin glargine) through its original application, establishing a concentrated long-acting insulin product for glycemi…
-
FDA approval · 2015-02-25FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Lantus SoloStar (insulin glargine) from sanofi-aventis U.S. LLC. The insulin product is used to …
-
FDA approval · 2015-02-25FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly, updating approval details for this product.
-
FDA approval · 2015-02-25FDA Approved: SYMLINPEN — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SymlinPen (pramlintide acetate) by AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2015-02-25FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk.